{"id":4996,"date":"2025-06-12T08:02:55","date_gmt":"2025-06-12T07:02:55","guid":{"rendered":"https:\/\/cbmeds.in\/?post_type=product&#038;p=4996"},"modified":"2025-06-12T08:04:12","modified_gmt":"2025-06-12T07:04:12","slug":"lytgobi-20-mg-futibatinib","status":"publish","type":"product","link":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib","title":{"rendered":"LYTGOBI 12MG\/ 20MG (FUTIBATINIB)"},"content":{"rendered":"<h2 id=\"uses\" class=\"ddc-anchor-offset\">What is Lytgobi?<\/h2>\n<p>&nbsp;<\/p>\n<p>Lytgobi (futibatinib) belongs to a class of medications called kinase inhibitors. Futibatinib works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.\u00a0 Lytgobi is used in adults to treat\u00a0<a href=\"https:\/\/www.drugs.com\/health-guide\/gallbladder-and-bile-duct-cancer.html\">bile duct cancer<\/a>\u00a0(cholangiocarcinoma) that has spread (metastatic) or cannot be removed by surgery:<\/p>\n<ul>\n<li>who have already received another treatment; and<\/li>\n<li>whose tumor has an abnormal &#8220;FGFR2&#8221; gene<\/li>\n<\/ul>\n<h2 data-start=\"44\" data-end=\"71\">\ud83d\udccc General Information<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"72\" data-end=\"275\">\n<li data-start=\"72\" data-end=\"113\">\n<p data-start=\"74\" data-end=\"113\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"14\" data-is-only-node=\"\">Brand Name<\/strong>: LYTGOBI<\/span><\/p>\n<\/li>\n<li data-start=\"114\" data-end=\"155\">\n<p data-start=\"116\" data-end=\"155\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"16\" data-is-only-node=\"\">Generic Name<\/strong>: Futibatinib<\/span><\/p>\n<\/li>\n<li data-start=\"156\" data-end=\"197\">\n<p data-start=\"158\" data-end=\"197\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"14\" data-is-only-node=\"\">Drug Class<\/strong>: Irreversible FGFR1\u20134 tyrosine kinase inhibitor<\/span><\/p>\n<\/li>\n<li data-start=\"198\" data-end=\"275\">\n<p data-start=\"200\" data-end=\"275\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"16\" data-is-only-node=\"\">Manufacturer<\/strong>: Taiho Oncology \/ Taiho Pharmaceuticals<\/span><\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"277\" data-end=\"280\" \/>\n<h2 data-start=\"282\" data-end=\"302\">\ud83c\udfe5 Approved Use<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"303\" data-end=\"462\">\n<li data-start=\"303\" data-end=\"383\">\n<p data-start=\"305\" data-end=\"383\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">For adults with <strong data-start=\"16\" data-end=\"122\">previously treated, unresectable locally advanced or metastatic intrahepatic cholangiocarcinoma (iCCA)<\/strong> harboring <strong data-start=\"133\" data-end=\"173\" data-is-last-node=\"\">FGFR2 gene fusions or rearrangements<\/strong><\/span><\/p>\n<\/li>\n<li data-start=\"384\" data-end=\"462\">\n<p data-start=\"386\" data-end=\"462\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Received <strong data-start=\"9\" data-end=\"37\">accelerated FDA approval<\/strong> on <strong data-start=\"41\" data-end=\"63\">September 30, 2022<\/strong>, based on Phase II data. Also approved in Japan (June 2023) and Europe (July 2023)<\/span><\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"464\" data-end=\"467\" \/>\n<h2 data-start=\"469\" data-end=\"500\">\ud83d\udc8a Dosage &amp; Administration<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"501\" data-end=\"753\">\n<li data-start=\"501\" data-end=\"585\">\n<p data-start=\"503\" data-end=\"585\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"20\" data-is-only-node=\"\">Recommended Dose<\/strong>: 20\u202fmg orally <strong data-start=\"35\" data-end=\"49\">once daily<\/strong>, until disease progression or unacceptable toxicity<\/span><\/p>\n<\/li>\n<li data-start=\"586\" data-end=\"670\">\n<p data-start=\"588\" data-end=\"670\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"29\" data-is-only-node=\"\">Dose Reduction Guidelines<\/strong>: First reduction to 16\u202fmg daily, then to 12\u202fmg daily; discontinue if 12\u202fmg not tolerated<\/span><\/p>\n<\/li>\n<li data-start=\"671\" data-end=\"753\">\n<p data-start=\"673\" data-end=\"753\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"18\" data-is-only-node=\"\">Administration<\/strong>: With or without food, taken at the same time each day. Swallow whole \u2014 do not crush or chew<\/span><\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"755\" data-end=\"758\" \/>\n<h2 data-start=\"760\" data-end=\"776\">\ud83d\udd2c Efficacy<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"777\" data-end=\"1041\">\n<li data-start=\"777\" data-end=\"1041\">\n<p data-start=\"779\" data-end=\"818\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Based on the FOENIX\u2011CCA2 Phase II trial:<\/span><\/p>\n<ul data-start=\"821\" data-end=\"1041\">\n<li data-start=\"821\" data-end=\"864\">\n<p data-start=\"823\" data-end=\"864\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"33\" data-is-only-node=\"\">Objective response rate (ORR)<\/strong>: 42%<\/span><\/p>\n<\/li>\n<li data-start=\"867\" data-end=\"910\">\n<p data-start=\"869\" data-end=\"910\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"31\" data-is-only-node=\"\">Median duration of response<\/strong>: 9.7 months<\/span><\/p>\n<\/li>\n<li data-start=\"913\" data-end=\"956\">\n<p data-start=\"915\" data-end=\"956\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"24\" data-is-only-node=\"\">Disease control rate<\/strong>: 83%<\/span><\/p>\n<\/li>\n<li data-start=\"959\" data-end=\"1041\">\n<p data-start=\"961\" data-end=\"1041\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"27\" data-is-only-node=\"\">Median time to response<\/strong>: 2.6 months<\/span> .<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<hr data-start=\"1043\" data-end=\"1046\" \/>\n<h2 data-start=\"1048\" data-end=\"1070\">\u26a0\ufe0f Safety Profile<\/h2>\n<p>&nbsp;<\/p>\n<h3 data-start=\"1072\" data-end=\"1107\">Common Adverse Effects<\/h3>\n<ul data-start=\"1108\" data-end=\"1190\">\n<li data-start=\"1108\" data-end=\"1190\">\n<p data-start=\"1110\" data-end=\"1190\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Diarrhea, fatigue, dry mouth, constipation, vomiting, nail disorders, musculoskeletal pain, dry skin, alopecia, stomatitis, arthralgia, dysgeusia, abdominal pain, UTI<\/span><\/p>\n<\/li>\n<\/ul>\n<h3 data-start=\"1192\" data-end=\"1214\">Notable Warnings<\/h3>\n<ul data-start=\"1215\" data-end=\"1382\">\n<li data-start=\"1215\" data-end=\"1299\">\n<p data-start=\"1217\" data-end=\"1299\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"19\" data-is-only-node=\"\">Ocular toxicity<\/strong>: Retinal pigment epithelial detachment in ~9%. Baseline ophthalmic exam + OCT every 2 months for 6 months, then every 3 months<\/span> <span class=\"\" data-state=\"closed\"><span class=\"ms-1 inline-flex max-w-full items-center relative top-[-0.094rem] animate-[show_150ms_ease-in]\"><a class=\"flex h-4.5 overflow-hidden rounded-xl px-2 text-[0.5625em] font-medium text-token-text-secondary! bg-[#F4F4F4]! dark:bg-[#303030]! transition-colors duration-150 ease-in-out\" href=\"https:\/\/www.taihooncology.com\/us\/news\/2022-09_lytgobi_approval\/?utm_source=chatgpt.com\" target=\"_blank\" rel=\"noopener\"><span class=\"relative start-0 bottom-0 flex h-full w-full items-center\"><span class=\"flex h-4 w-full items-center justify-between overflow-hidden\"><span class=\"max-w-full grow truncate overflow-hidden text-center\">taihooncology.com<\/span><\/span><\/span><\/a><\/span><\/span>.<\/p>\n<\/li>\n<li data-start=\"1300\" data-end=\"1382\">\n<p data-start=\"1302\" data-end=\"1382\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"20\" data-is-only-node=\"\">Serious toxicity<\/strong>: Hepatic, renal, electrolyte imbalances; monitor regularly via labs<\/span> .<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"1384\" data-end=\"1387\" \/>\n<h2 data-start=\"1389\" data-end=\"1416\">\ud83d\udd0d Regulatory Reminder<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"1417\" data-end=\"1499\">\n<li data-start=\"1417\" data-end=\"1499\">\n<p data-start=\"1419\" data-end=\"1499\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">In early 2025, the FDA flagged <strong data-start=\"31\" data-end=\"61\">misleading efficacy claims<\/strong> on LYTGOBI\u2019s HCP website, noting that single-arm phase II data cannot meaningfully support PFS\/OS statements<\/span><\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"1501\" data-end=\"1504\" \/>\n<h2 data-start=\"1506\" data-end=\"1537\">\ud83c\uddee\ud83c\uddf3 Availability in India<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"1538\" data-end=\"1785\">\n<li data-start=\"1538\" data-end=\"1622\">\n<p data-start=\"1540\" data-end=\"1622\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"35\" data-is-only-node=\"\">Import via Named Patient Supply<\/strong>: Companies like Indian Pharma Network (IPN) and Medvitaz Pharma can facilitate importation through Form 12A\/12B channels<\/span><\/p>\n<\/li>\n<li data-start=\"1623\" data-end=\"1785\">\n<p data-start=\"1625\" data-end=\"1785\"><strong data-start=\"1625\" data-end=\"1643\">Access process<\/strong>: Requires FGFR2\u2011fusion positive test, oncologist prescription, and procedure documentation. Targeted for cities nationwide, including Indore.<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"1787\" data-end=\"1790\" \/>\n<h2 data-start=\"1792\" data-end=\"1806\">\u2705 Summary<\/h2>\n<p>&nbsp;<\/p>\n<p data-start=\"1807\" data-end=\"2268\">LYTGOBI (futibatinib) is the first <strong data-start=\"1843\" data-end=\"1874\">irreversible FGFR inhibitor<\/strong> for advanced FGFR2-positive iCCA. It offers significant response rates (\u224842%) and decent duration of response (~9\u201310 months). While generally well-tolerated, it requires regular monitoring for eye, liver, and metabolic issues, and adherence to dose modifications. Patients and physicians should be informed about ongoing regulatory considerations and careful interpretation of efficacy claims.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong data-start=\"44\" data-end=\"58\">Brand Name <\/strong>: <strong data-start=\"60\" data-end=\"72\">LYTGOBI<\/strong><br data-start=\"72\" data-end=\"75\" \/><strong data-start=\"75\" data-end=\"96\">Salt\/Generic Name <\/strong>: <strong data-start=\"98\" data-end=\"113\">Futibatinib<\/strong> (hydrochloride)<br data-start=\"129\" data-end=\"132\" \/><strong data-start=\"132\" data-end=\"148\">Manufacturer <\/strong>: <strong data-start=\"150\" data-end=\"184\">Taiho Pharmaceutical Co., Ltd.<\/strong><br data-start=\"219\" data-end=\"222\" \/><strong data-start=\"222\" data-end=\"248\">Formulation &amp; Strength <\/strong>: Oral tablets, <strong data-start=\"264\" data-end=\"273\">20\u202fmg<\/strong><br data-start=\"273\" data-end=\"276\" \/><strong data-start=\"276\" data-end=\"290\">Indication <\/strong>: Treatment of unresectable or metastatic intrahepatic cholangiocarcinoma in adults with FGFR2 gene fusions\/rearrangements after prior systemic therapy<\/p>\n","protected":false},"featured_media":4999,"comment_status":"open","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[91],"product_tag":[],"class_list":{"0":"post-4996","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-bile-duct-cancer","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LYTGOBI 12MG\/ 20MG (FUTIBATINIB) - Curiance Biotech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LYTGOBI 12MG\/ 20MG (FUTIBATINIB) - Curiance Biotech\" \/>\n<meta property=\"og:description\" content=\"Brand Name : LYTGOBISalt\/Generic Name : Futibatinib (hydrochloride)Manufacturer : Taiho Pharmaceutical Co., Ltd.Formulation &amp; Strength : Oral tablets, 20\u202fmgIndication : Treatment of unresectable or metastatic intrahepatic cholangiocarcinoma in adults with FGFR2 gene fusions\/rearrangements after prior systemic therapy\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib\" \/>\n<meta property=\"og:site_name\" content=\"Curiance Biotech\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-12T07:04:12+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/LYTGOBI-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1103\" \/>\n\t<meta property=\"og:image:height\" content=\"618\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib\",\"name\":\"LYTGOBI 12MG\\\/ 20MG (FUTIBATINIB) - Curiance Biotech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/LYTGOBI-2.jpg\",\"datePublished\":\"2025-06-12T07:02:55+00:00\",\"dateModified\":\"2025-06-12T07:04:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib#primaryimage\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/LYTGOBI-2.jpg\",\"contentUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/LYTGOBI-2.jpg\",\"width\":1103,\"height\":618},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=lytgobi-20-mg-futibatinib#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cbmeds.in\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\\\/\\\/cbmeds.in\\\/?page_id=13\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"LYTGOBI 12MG\\\/ 20MG (FUTIBATINIB)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#website\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/\",\"name\":\"cbmeds.in\",\"description\":\"Tomorrow&#039;s Medicine Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#organization\"},\"alternateName\":\"Curiance Biotech\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cbmeds.in\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#organization\",\"name\":\"CB Meds\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-1-1-1.png\",\"contentUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-1-1-1.png\",\"width\":640,\"height\":640,\"caption\":\"CB Meds\"},\"image\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LYTGOBI 12MG\/ 20MG (FUTIBATINIB) - Curiance Biotech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib","og_locale":"en_US","og_type":"article","og_title":"LYTGOBI 12MG\/ 20MG (FUTIBATINIB) - Curiance Biotech","og_description":"Brand Name : LYTGOBISalt\/Generic Name : Futibatinib (hydrochloride)Manufacturer : Taiho Pharmaceutical Co., Ltd.Formulation &amp; Strength : Oral tablets, 20\u202fmgIndication : Treatment of unresectable or metastatic intrahepatic cholangiocarcinoma in adults with FGFR2 gene fusions\/rearrangements after prior systemic therapy","og_url":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib","og_site_name":"Curiance Biotech","article_modified_time":"2025-06-12T07:04:12+00:00","og_image":[{"width":1103,"height":618,"url":"http:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/LYTGOBI-2.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib","url":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib","name":"LYTGOBI 12MG\/ 20MG (FUTIBATINIB) - Curiance Biotech","isPartOf":{"@id":"https:\/\/cbmeds.in\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib#primaryimage"},"image":{"@id":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib#primaryimage"},"thumbnailUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/LYTGOBI-2.jpg","datePublished":"2025-06-12T07:02:55+00:00","dateModified":"2025-06-12T07:04:12+00:00","breadcrumb":{"@id":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib#primaryimage","url":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/LYTGOBI-2.jpg","contentUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/LYTGOBI-2.jpg","width":1103,"height":618},{"@type":"BreadcrumbList","@id":"https:\/\/cbmeds.in\/?product=lytgobi-20-mg-futibatinib#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cbmeds.in\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/cbmeds.in\/?page_id=13"},{"@type":"ListItem","position":3,"name":"LYTGOBI 12MG\/ 20MG (FUTIBATINIB)"}]},{"@type":"WebSite","@id":"https:\/\/cbmeds.in\/#website","url":"https:\/\/cbmeds.in\/","name":"cbmeds.in","description":"Tomorrow&#039;s Medicine Today","publisher":{"@id":"https:\/\/cbmeds.in\/#organization"},"alternateName":"Curiance Biotech","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cbmeds.in\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cbmeds.in\/#organization","name":"CB Meds","url":"https:\/\/cbmeds.in\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cbmeds.in\/#\/schema\/logo\/image\/","url":"https:\/\/cbmeds.in\/wp-content\/uploads\/2023\/09\/Logo-1-1-1.png","contentUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2023\/09\/Logo-1-1-1.png","width":640,"height":640,"caption":"CB Meds"},"image":{"@id":"https:\/\/cbmeds.in\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/product\/4996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/product"}],"about":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4996"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/media\/4999"}],"wp:attachment":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4996"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_brand&post=4996"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_cat&post=4996"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_tag&post=4996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}